Search results

Found 49 pages
AUTHOR: Claire Bowie

Results per page

10 20 50 100

Sort by

Relevance Date

19 Jun 2009:

NICE opens consultation on patient access and flexible pricing

The National Institute for Health and Clinical Excellence has launched a one-month consultation period to review patient access and flexible pricing schemes as part of a product’s appraisal for use on the National Health Service. - News -

by Claire Bowie

https://www.pharmatimes.com/news/nice_opens_consultation_on_patient_access_and_flexible_pricing_984649

16 Nov 2010:

Bayer’s Xarelto outshines warfarin in stroke prevention trial

Shares in Germany’s Bayer jumped 4% yesterday after the company revealed its once daily oral clotbuster Xarelto (rivaroxaban) was superior to the gold standard warfarin, with less risk of bleeding, in protecting against stroke among patients with

by Claire Bowie

https://www.pharmatimes.com/news/bayers_xarelto_outshines_warfarin_in_stroke_prevention_trial_982059

8 Oct 2009:

Stronger US sales drive pharma growth in 2010

The global pharmaceutical market in 2010 is expected to grow 4%-6% on a constant-dollar basis, exceeding $825 billion, driven by stronger near-term growth in the US market, according to the latest figures from IMS Health. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/stronger_us_sales_drive_pharma_growth_in_2010_984486

30 Jun 2009:

EMEA to investigate Lantus as analysts lower forecasts

Analysts have swooped in on the Franco-German firm after its blockbuster diabetes drug Lantus (insulin glargine) was linked to cancer in the journal Diabetologia. Though the association is not conclusive, cautious analysts have drastically lowered

by Claire Bowie

https://www.pharmatimes.com/news/emea_to_investigate_lantus_as_analysts_lower_forecasts_984582

27 Feb 2007:

Dementia costs the UK nearly £540 per second, says report

Dementia costs the UK £17 billion per year, yet the government has no plan on how to deal with dementia now or in the future, according to a report from the Alzheimer's Society. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/dementia_costs_the_uk_nearly_540_per_second,_says_report_989450

11 Oct 2007:

Merck Serono's Rebif fails to show Copaxone superiority

Merck Serono’s multiple sclerosis drug Rebif (interferon beta-1a) has failed to show superiority over rival Teva’s Copaxone (glatiramer acetate) in patients with the relapsing remitting form of the disease, according to media reports this morning

by Claire Bowie

https://www.pharmatimes.com/news/merck_seronos_rebif_fails_to_show_copaxone_superiority_991090

7 Nov 2013:

Health systems need 'fundamental overhaul'

The rate of innovation continues to outstrip what was ever thought possible, but we need to rethink and turn our way of approaching the future on its head. If we go from the current reality – shaped first by our business, then the market and

by Claire Bowie

https://www.pharmatimes.com/news/health_systems_need_fundamental_overhaul_1005975

24 Jan 2008:

Bayer pulls Leukine from US, positive Nexavar news in Japan

German powerhouse Bayer is to pull a formulation of its anti-infective Leukine (sargramostim) from the USA following a spike in the number of adverse events reported, particularly fainting and hypotension. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/bayer_pulls_leukine_from_us,_positive_nexavar_news_in_japan_985910

28 Jun 2011:

One in three diabetes patients don’t adhere to treatment

One third of diabetes patients miss taking their insulin treatment an average three times a month, according to an international study involving more than 1,500 type 1 and type 2 diabetics. And the situation is even more critical in the UK where one

by Claire Bowie

https://www.pharmatimes.com/news/one_in_three_diabetes_patients_dont_adhere_to_treatment_980804

30 Aug 2013:

Sales reps struggling with the new NHS environment

Just 20% of representatives taking part in a recent cross-industry benchmarking competition feel very well informed about the NHS changes, according to a new Sales Insights report from PharmaTimes. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/sales_reps_struggling_with_the_new_nhs_environment_1005617